U.S. markets closed

Daré Bioscience, Inc. (DARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3000+0.0600 (+4.84%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
0
0
Operating Expense
27,402
27,402
14,345
11,695
3,690
Operating Income
-27,402
-27,402
-14,345
-11,695
-3,690
Net Non Operating Interest Income Expense
-
-
-
-
-322.629
Other Income Expense
1.514
1.514
81.05
-5,044
-7,491
Pretax Income
-27,401
-27,401
-14,264
-16,739
-11,503
Net Income Common Stockholders
-27,408
-27,408
-15,053
-16,739
-11,503
Diluted NI Available to Com Stockholders
-27,408
-27,408
-15,053
-16,739
-11,503
Basic EPS
-
-
-0.97
-1.57
-3.56
Diluted EPS
-
-
-0.97
-1.57
-3.56
Basic Average Shares
-
-
15,579
10,732
3,232
Diluted Average Shares
-
-
15,579
10,732
3,232
Total Operating Income as Reported
-27,402
-27,402
-14,345
-16,882
-11,180
Total Expenses
27,402
27,402
14,345
11,695
3,690
Net Income from Continuing & Discontinued Operation
-27,401
-27,401
-14,264
-16,739
-11,503
Normalized Income
-27,401
-27,401
-14,264
-11,551
-4,012
Interest Expense
-
-
-
-
322.629
Net Interest Income
-
-
-
-
-322.629
EBIT
-27,402
-27,402
-14,345
-11,695
-11,180
EBITDA
-27,359
-
-
-
-
Reconciled Depreciation
43.227
43.227
11.137
2.44
-
Net Income from Continuing Operation Net Minority Interest
-27,401
-27,401
-14,264
-16,739
-11,503
Total Unusual Items Excluding Goodwill
-
-
0
-5,188
-7,491
Total Unusual Items
-
-
0
-5,188
-7,491
Normalized EBITDA
-27,359
-27,359
-14,334
-6,505
-3,690
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0